Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.20
-0.03 (-0.48%)
Mar 9, 2026, 3:33 PM EDT - Market open
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $292.85 million as of March 9, 2026. Its market cap has increased by 24.05% in one year.
Market Cap
292.85M
Enterprise Value
209.31M
1-Year Change
24.05%
Ranking
Category
Stock Price
$6.20
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $292.85M, a decrease of -45.60%. That is a compound annual growth rate of -10.49%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 316.16M |
| Nautilus Biotechnology | 312.61M |
| XOMA Royalty | 308.86M |
| Puma Biotechnology | 307.80M |
| Cabaletta Bio | 305.16M |
| C4 Therapeutics | 296.64M |
| ALX Oncology Holdings | 289.95M |
| Aldeyra Therapeutics | 288.88M |